Pharmacokinetics of Meloxicam in Different Animal Species: A Comprehensive Review

[EN] Meloxicam is a non-steroidal anti-inflammatory in the oxicam group. It has been extensively used in human and veterinary medicine for their anti-inflammatory, analgesic and antipyretic activities. Meloxicam has shown high therapeutic potential for disorders such as osteoarthritis, musculoskelet...

ver descrição completa

Detalhes bibliográficos
Autores: Puente García, Raúl de la, Díez Láiz, Raquel, Diez Liébana, María José, Fernández Martínez, María Nélida, Sahagún Prieto, Ana María, Rodríguez Lago, José Manuel, García Viéitez, Juan José, López Cadenas, Cristina
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Recursos:Universidad de León
Repositorio:BULERIA. Repositorio Institucional de la Universidad de León
OAI Identifier:oai:buleria.unileon.es:10612/26006
Acesso em linha:https://www.mdpi.com/2306-7381/11/11/519
https://hdl.handle.net/10612/26006
Access Level:acceso abierto
Palavra-chave:Farmacología
Veterinaria
Pharmacokinetics
Animal species
Meloxicam
Absorption
Distribution
Metabolism
Excretion
3109 Ciencias Veterinarias
3109.08 Farmacología
Descrição
Resumo:[EN] Meloxicam is a non-steroidal anti-inflammatory in the oxicam group. It has been extensively used in human and veterinary medicine for their anti-inflammatory, analgesic and antipyretic activities. Meloxicam has shown high therapeutic potential for disorders such as osteoarthritis, musculoskeletal disorder, acute respiratory infection, puerperal septicemia, mastitis and mastitis–metritis–agalactia syndrome. Although meloxicam pharmacokinetic has been described for numerous species, no paper summarizes the existing literature on this field. Thus, the aim of this review was to carry out a review of the literature on the pharmacokinetics of meloxicam in different animal species and gather the data in a single review article. A comprehensive review of the available literature in the PubMed, Web of Science and Scopus databases was performed. Meloxicam shows good bioavailability after oral and parenteral administration in most animal species (85–95%), with the lowest values in sheep after oral administration. It presents a rapid distribution with a small volume of distribution, which can be attributed to relatively high ionization state of meloxicam at physiological pH and its high plasma protein binding (close to 99%). It is extensively metabolized in the liver in several inactive polar metabolites, which are excreted, like unchanged meloxicam in urine and feces. Meloxicam also shows a long elimination half-life and low clearance